News

Roche will invest $550 million in Indianapolis for a new manufacturing facility for glucose monitoring devices, adding ...
Continuous glucose monitoring provides a new, less invasive method for evaluating diabetes risk. Fluctuations in blood ...
Continuous glucose monitoring can now spot early diabetes risks, offering a non-invasive alternative to traditional blood ...
The Swiss biotech company Roche on Monday announced plans for a $550 million expansion of its Indianapolis diagnostics and ...
Long-term clinical evaluation represents key advancement following successful first-in-human studyRUTHERFORD, N.J., May 13, 2025 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or ...
Roche Diagnostics plans to produce glucose monitors at the site within three years and prepare for future generations of its ...
I wore Dexcom’s over-the-counter blood glucose monitor for a month. Here’s how it compares to Lingo and what it’s like to use ...
Roche said Monday it plans to invest up to $550 million and add hundreds of jobs over the next five years at its Indianapolis ...
Is there such a thing as pre-prediabetes? My doctor says it’s happening to me, and he wants me to use one of those blood ...
Roche announces $550 million investment to make Indianapolis a hub for diabetes monitoring solution manufacturing. Roche expects to create hundreds of highly-skilled manufacturing jobs and thousands ...
Both Meal and Glucose are now available to Oura members on iOS and Android in the US. The company says international ...
How wearables are reshaping chronic disease management with real-time data, personalized treatment, and early intervention ...